FDAnews
www.fdanews.com/articles/85038-liponex-inc-announces-results-for-year-ended-december-31-2005

LIPONEX INC. ANNOUNCES RESULTS FOR YEAR ENDED DECEMBER 31, 2005

March 6, 2006

Liponex Inc., a biopharmaceutical company specializing in developing advanced products related to High Density Lipoprotein (HDL), often called "good cholesterol," today announced its results for the year ended December 31, 2005. "In 2005 we were able to take the first step toward moving our lead compound into later stage clinical testing by successfully completing our initial public offering," said Bill Dickie, President and CEO.
CNW Group